JP2018530581A5 - - Google Patents

Download PDF

Info

Publication number
JP2018530581A5
JP2018530581A5 JP2018519274A JP2018519274A JP2018530581A5 JP 2018530581 A5 JP2018530581 A5 JP 2018530581A5 JP 2018519274 A JP2018519274 A JP 2018519274A JP 2018519274 A JP2018519274 A JP 2018519274A JP 2018530581 A5 JP2018530581 A5 JP 2018530581A5
Authority
JP
Japan
Prior art keywords
dmso
soluble
dissolved
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018519274A
Other languages
English (en)
Japanese (ja)
Other versions
JP6957455B2 (ja
JP2018530581A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/056528 external-priority patent/WO2017066240A1/en
Publication of JP2018530581A publication Critical patent/JP2018530581A/ja
Publication of JP2018530581A5 publication Critical patent/JP2018530581A5/ja
Priority to JP2021164809A priority Critical patent/JP2022008902A/ja
Application granted granted Critical
Publication of JP6957455B2 publication Critical patent/JP6957455B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018519274A 2015-10-14 2016-10-12 ベータ細胞の複製及び／または生存の亢進 Active JP6957455B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021164809A JP2022008902A (ja) 2015-10-14 2021-10-06 ベータ細胞の複製及び／または生存の亢進

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201562241566P 2015-10-14 2015-10-14
US62/241,566 2015-10-14
US201662279908P 2016-01-18 2016-01-18
US62/279,908 2016-01-18
PCT/US2016/056528 WO2017066240A1 (en) 2015-10-14 2016-10-12 Enhancing beta cell replication and/or survival

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021164809A Division JP2022008902A (ja) 2015-10-14 2021-10-06 ベータ細胞の複製及び／または生存の亢進

Publications (3)

Publication Number Publication Date
JP2018530581A JP2018530581A (ja) 2018-10-18
JP2018530581A5 true JP2018530581A5 (https=) 2019-05-09
JP6957455B2 JP6957455B2 (ja) 2021-11-02

Family

ID=58518528

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018519274A Active JP6957455B2 (ja) 2015-10-14 2016-10-12 ベータ細胞の複製及び／または生存の亢進
JP2021164809A Pending JP2022008902A (ja) 2015-10-14 2021-10-06 ベータ細胞の複製及び／または生存の亢進

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021164809A Pending JP2022008902A (ja) 2015-10-14 2021-10-06 ベータ細胞の複製及び／または生存の亢進

Country Status (7)

Country Link
US (1) US20180235916A1 (https=)
EP (1) EP3362069A4 (https=)
JP (2) JP6957455B2 (https=)
KR (1) KR20180054796A (https=)
CN (1) CN108697712A (https=)
AU (2) AU2016338916B2 (https=)
WO (1) WO2017066240A1 (https=)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG10201606063RA (en) 2012-01-23 2016-09-29 Sage Therapeutics Inc Neuroactive steroid formulations and methods of treating cns disorders
MX2015002252A (es) 2012-08-21 2015-07-21 Sage Therapeutics Inc Metodos para tratar epilepsia o estado de epilepsia.
DK2925327T3 (da) 2012-11-30 2024-03-25 Univ California Allopregnanolon til behandling, reduktion eller lindring af symptomer på fødselsdepression
JOP20200195A1 (ar) 2014-09-08 2017-06-16 Sage Therapeutics Inc سترويدات وتركيبات نشطة عصبياً، واستخداماتها
HK1258616A1 (zh) 2016-03-08 2019-11-15 Sage Therapeutics, Inc. 神经活性类固醇、组合物、及其用途
CA3104810A1 (en) * 2017-06-23 2018-12-27 The Regents Of The University Of California Enhancing gaba's ability to modulate immune responses
US20210353751A1 (en) * 2018-10-18 2021-11-18 The Regents Of The University Of California Combination therapies for treatment of inflammatory diseases
JP2023509981A (ja) * 2020-01-10 2023-03-10 エキリーブル バイオファーマシューティカルズ べスローテン フェンノートシャップ アベルメクチンによる神経障害の治療
US20250375429A1 (en) * 2024-05-29 2025-12-11 Smarter Not Harder, Inc. Obligate pairing of orthosteric and non-orthosteric gaba ligands in pharmaceutical formulations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3503300A (en) * 1999-02-24 2000-09-14 Regents Of The University Of California, The Gaba receptors mediate inhibition of t cell responses
WO2012050907A2 (en) * 2010-09-28 2012-04-19 The Regents Of The University Of California Gaba agonists in the treatment of disorders associated with metabolic syndrome and gaba combinations in treatment or prophylaxis of type i diabetes
EP2900820B2 (en) * 2012-09-27 2020-11-18 Institut National de la Sante et de la Recherche Medicale (INSERM) Methods for producing a population of pancreatic beta-cells
PL3119744T3 (pl) * 2014-03-18 2019-07-31 Algiax Pharmaceuticals Gmbh Pochodne 2-cyjano-3-cyklopropylo-3-hydroksy-N-arylo-tioakryloamidu

Similar Documents

Publication Publication Date Title
JP2018530581A5 (https=)
HUE054103T2 (hu) Izokinolin-3-il-karboxamidok, ezek elõállítása és alkalmazása
JP2017514877A5 (https=)
JP2014237817A5 (https=)
JP2016196495A5 (https=)
HUE053737T2 (hu) Piridopirrolokinoxalin vegyületek, készítményeik és alkalmazásaik
JP2016028081A5 (https=)
DK3297637T3 (da) Benzen-1,3,5-tricarboxamidderivater og anvendelser deraf
JP2017519346A5 (https=)
JP2016503708A5 (https=)
FIC20250026I1 (fi) Niraparibi tai sen farmaseuttisesti hyväksytty suola etenkin niraparibitosylaatti etenkin niraparibitosylaattimonohydraatti, valinnaisesti yhdessä abirateronin ja erityisesti abirateroniasetaatin kanssa.
HUE054037T2 (hu) CD71 elleni, aktiválható antitest hatóanyag konjugátumok és eljárások alkalmazásukra
SG11201801534RA (en) 1,7-diaryl-1,6-heptadiene-3,5-dione derivatives, methods for the production and use thereof
DK3612579T3 (da) Pultrudat, fremstilling og anvendelse heraf
MX2017006953A (es) Medicamentos para disminuir la evolucion de la enfermedad de parkinson.
TWI561508B (en) Onium salt, chemically amplified positive resist composition, and patterning process
JP2015173751A5 (https=)
HUE070649T2 (hu) Benzimidazol-származékok és felhasználásuk
JP2016540019A5 (https=)
DK3402783T3 (da) 3-(carboxyethyl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decan-derivater
LT3402785T (lt) 3-(karboksimetil)-8-amino-2-okso-1,3-diaza-spiro-[4.5]-dekano dariniai
JP2015016294A5 (https=)
JP2017528459A5 (https=)
JP2017149782A5 (https=)
JP2017197541A5 (https=)